Cytosorbents Corp Shares Close in on 52-Week Low - Market Mover
The shares closed 0.5% above its 52-week low of $4.26, with trading volume higher than its 30 day average
Dec 22, 2021 by Kwhen Finance Editors
Cytosorbents Corp (CTSO) shares closed today at 0.5% above its 52 week low of $4.26, giving the company a market cap of $185M. The stock is currently down 46.5% year-to-date, down 49.8% over the past 12 months, and down 14.8% over the past five years. This week, the Dow Jones Industrial Average fell 2.0%, and the S&P 500 fell 2.1%.
Trading Activity
- Trading volume this week was 39.5% higher than the 20-day average.
- Beta, a measure of the stock’s volatility relative to the overall market stands at 0.8.
Technical Indicators
- The Relative Strength Index (RSI) on the stock was under 30, indicating it may be underbought.
- MACD, a trend-following momentum indicator, indicates a downward trend.
- The stock closed below its Bollinger band, indicating it may be oversold.
Market Comparative Performance
- The company's share price is the same as the S&P 500 Index , lags it on a 1-year basis, and lags it on a 5-year basis
- The company's share price is the same as the Dow Jones Industrial Average , lags it on a 1-year basis, and lags it on a 5-year basis
- The company share price is the same as the performance of its peers in the Health Care industry sector , lags it on a 1-year basis, and lags it on a 5 year basis
| Name | DoD %Δ | YTD %Δ | 1 Yr % | 52-Week H % | 52-Week L % |
|---|---|---|---|---|---|
| Cytosorbents Corp | 0.5 | -46.5 | -49.8 | -63.5 | 0.0 |
| Dow Jones Industrial Average | 1.6 | 16.2 | 17.6 | -3.3 | 19.9 |
| S&P 500 Index | 1.8 | 23.3 | 24.9 | -2.8 | 27.4 |
| Health Care | 0.6 | 19.8 | 20.3 | -1.4 | 24.2 |
Peer Group Comparative Performance
- The company's stock price performance year-to-date lags the peer average by 2032.8%
- The company's stock price performance over the past 12 months lags the peer average by 1710.6%
| Name | MKT CAP (USD) | P/E | YTD %Δ | 1 Yr %Δ | 52-Week H % | 52-Week L % |
|---|---|---|---|---|---|---|
| Cytosorbents Corp | CTSO | 0 | -46.5 | -49.8 | -63.5 | 0 |
| Peer Avg | N/A | 10.4 | -2.2 | -2.7 | -23.0 | 16.2 |
| Boston Scientific Corp. | BSX | 51.1 | 9.9 | 11.4 | -13.7 | 16.9 |
| Hologic, Inc. | HOLX | 5.2 | 6.0 | 3.2 | -8.9 | 28.9 |
| Meridian Bioscience Inc. | VIVO | 6.0 | 6.0 | -4.1 | -35.5 | 16.4 |
| Nephros Inc | NEPH | 0 | -23.0 | -13.9 | -42.8 | 7.1 |
| Daxor Corporation | DXR | 0 | -12.0 | -13.1 | -37.4 | 28.2 |
This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to editors@kwhen.com. © 2021 Kwhen Inc.
Was this content valuable for you?
Tags: